PeopleBio, Inc. (KOSDAQ: 304840)
South Korea
· Delayed Price · Currency is KRW
3,160.00
-90.00 (-2.77%)
Dec 19, 2024, 2:34 PM KST
PeopleBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 637.84 | 691.18 | 13,643 | 38,810 | 6,260 |
Short-Term Investments | 6,620 | 4,553 | 9,020 | 120.3 | 3,105 |
Cash & Short-Term Investments | 8,258 | 5,244 | 22,664 | 38,930 | 9,365 |
Cash Growth | 58.72% | -76.86% | -41.78% | 315.70% | - |
Accounts Receivable | 3,390 | 3,140 | 1,638 | 52.75 | 229.9 |
Other Receivables | 60.49 | 53.9 | 62.53 | 14.44 | 50.63 |
Receivables | 4,250 | 3,994 | 1,700 | 290.08 | 280.53 |
Inventory | 2,506 | 2,311 | 540.33 | 327.33 | 167.22 |
Prepaid Expenses | 221.39 | 213.28 | 473.49 | 159.14 | 95.01 |
Other Current Assets | 4,218 | 3,047 | 3,964 | 438.43 | 191.69 |
Total Current Assets | 19,454 | 14,810 | 29,341 | 40,145 | 10,099 |
Property, Plant & Equipment | 2,662 | 3,550 | 3,672 | 2,289 | 383.74 |
Long-Term Investments | 4,968 | 5,753 | 5,584 | 5,020 | - |
Goodwill | 379.86 | 379.86 | 379.86 | 379.86 | - |
Other Intangible Assets | 2,354 | 2,601 | 2,918 | 3,225 | 74.99 |
Other Long-Term Assets | 502.33 | 486.75 | 421.4 | 289.44 | 96.75 |
Total Assets | 30,320 | 27,580 | 42,316 | 51,348 | 10,655 |
Accounts Payable | 68.25 | 104.63 | 261.26 | 9.4 | 109.27 |
Accrued Expenses | 367.72 | 519.67 | 316.07 | 110.17 | 87.84 |
Short-Term Debt | 9,121 | 895.67 | 14,543 | 12,412 | - |
Current Portion of Long-Term Debt | 3.81 | 3.54 | 4.06 | 4.68 | - |
Current Portion of Leases | 463.01 | 541.49 | 420.18 | 295.67 | 144.78 |
Other Current Liabilities | 6,548 | 1,468 | 17,292 | 16,434 | 165.36 |
Total Current Liabilities | 16,571 | 3,533 | 32,836 | 29,266 | 507.25 |
Long-Term Debt | 432.44 | 435.33 | 438.8 | 442.78 | - |
Long-Term Leases | 384.67 | 678.37 | 945.83 | 592.84 | 70.95 |
Other Long-Term Liabilities | 162.95 | 146.17 | 116.36 | 66.87 | 0 |
Total Liabilities | 21,015 | 7,917 | 36,392 | 32,332 | 1,827 |
Common Stock | 10,545 | 10,545 | 5,906 | 5,622 | 2,824 |
Additional Paid-In Capital | 76,754 | 76,754 | 49,432 | 46,626 | 36,761 |
Retained Earnings | -77,674 | -68,450 | -51,549 | -37,228 | -32,361 |
Treasury Stock | -26.02 | -26.02 | - | - | - |
Comprehensive Income & Other | -0 | -0 | -0 | 1,604 | 1,604 |
Total Common Equity | 9,599 | 18,823 | 3,789 | 16,625 | 8,828 |
Minority Interest | -641.93 | 492.52 | 1,845 | 2,101 | - |
Shareholders' Equity | 9,305 | 19,664 | 5,924 | 19,016 | 8,828 |
Total Liabilities & Equity | 30,320 | 27,580 | 42,316 | 51,348 | 10,655 |
Total Debt | 10,405 | 2,554 | 16,352 | 13,748 | 215.73 |
Net Cash (Debt) | -2,147 | 2,690 | 6,312 | 25,182 | 9,149 |
Net Cash Growth | - | -57.39% | -74.94% | 175.24% | - |
Net Cash Per Share | -100.12 | 162.28 | 431.46 | 1569.96 | 753.92 |
Filing Date Shares Outstanding | 0.06 | 21.03 | 14.11 | 13.43 | 6.72 |
Total Common Shares Outstanding | 0.06 | 21.03 | 14.11 | 13.43 | 6.72 |
Working Capital | 2,882 | 11,276 | -3,495 | 10,879 | 9,592 |
Book Value Per Share | 165932.19 | 894.97 | 268.43 | 1237.50 | 1314.28 |
Tangible Book Value | 6,865 | 15,842 | 490.71 | 13,020 | 8,753 |
Tangible Book Value Per Share | 118670.72 | 753.25 | 34.77 | 969.16 | 1303.12 |
Machinery | 2,590 | 2,570 | 2,230 | 1,187 | 380.45 |
Construction In Progress | - | - | - | 204.75 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.